Evidence map›Paper›PMID 38486752›Full record

ArticleHeliyon2024

Pro-angiogenic and antibacterial copper containing nanoparticles in PLGA/amorphous calcium phosphate bone nanocomposites.

Lukas Näf, Iris Miescher, Lara Pfuderer, Tiziano A Schweizer, David Brunner, Johannes Dürig, Olivier Gröninger, Julia Rieber, Gabriella Meier-Buergisser, Katharina Spanaus and 5 more

Open access · goldAbstract read
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Engineering copper and copper-based materials for a post-antibiotic era.Frontiers in bioengineering and biotechnology · 2025
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Lukas NäfDepartment of Plastic Surgery and Hand Surgery, University Hospital of Zürich, Rämistrasse 100, 8091, Zürich, Switzerland.
Iris MiescherDepartment of Plastic Surgery and Hand Surgery, University Hospital of Zürich, Rämistrasse 100, 8091, Zürich, Switzerland.
Lara PfudererInstitute for Chemical and Bioengineering, Department of Chemistry and Applied Biosciences, ETH Zurich, CH-8093, Zurich, Switzerland.
Tiziano A SchweizerDepartment of Dermatology, University Hospital Zurich, University of Zurich, Rämistrasse 100, 8091, Zurich, Switzerland.
David BrunnerDepartment of Plastic Surgery and Hand Surgery, University Hospital of Zürich, Rämistrasse 100, 8091, Zürich, Switzerland.
Johannes DürigDepartment of Plastic Surgery and Hand Surgery, University Hospital of Zürich, Rämistrasse 100, 8091, Zürich, Switzerland.
Olivier GröningerInstitute for Chemical and Bioengineering, Department of Chemistry and Applied Biosciences, ETH Zurich, CH-8093, Zurich, Switzerland.
Julia RieberDepartment of Plastic Surgery and Hand Surgery, University Hospital of Zürich, Rämistrasse 100, 8091, Zürich, Switzerland.
Gabriella Meier-BuergisserDepartment of Plastic Surgery and Hand Surgery, University Hospital of Zürich, Rämistrasse 100, 8091, Zürich, Switzerland.
Katharina SpanausClinical Chemistry, University Hospital Zurich, 8001, Zurich, Switzerland.
Maurizio CalcagniDepartment of Plastic Surgery and Hand Surgery, University Hospital of Zürich, Rämistrasse 100, 8091, Zürich, Switzerland.
Philipp P BosshardDepartment of Dermatology, University Hospital Zurich, University of Zurich, Rämistrasse 100, 8091, Zurich, Switzerland.
Yvonne AchermannDepartment of Dermatology, University Hospital Zurich, University of Zurich, Rämistrasse 100, 8091, Zurich, Switzerland.
Wendelin J StarkInstitute for Chemical and Bioengineering, Department of Chemistry and Applied Biosciences, ETH Zurich, CH-8093, Zurich, Switzerland.
Johanna BuschmannDepartment of Plastic Surgery and Hand Surgery, University Hospital of Zürich, Rämistrasse 100, 8091, Zürich, Switzerland.
University Hospital of Zurich · CHETH Zurich · CHUniversity of Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Large bone defects after trauma demand for adequate bone substitutes. Bone void fillers should be antibacterial and pro-angiogenic. One viable option is the use of composite materials like the combination of PLGA and amorphous calcium phosphate (aCaP). Copper stimulates angiogenesis and has antibacterial qualities. Either copper oxide (CuO) nanoparticles (NPs) were therefore added to PLGA/aCaP/CuO in different concentrations (1, 5 and 10 w/w %) or copper-doped tricalcium phosphate NPs (TCP with 2% of copper) were electrospun into PLGA/CuTCP nanocomposites. Bi-layered nanocomposites of PLGA/aCaP with different copper NPs (CuO or TCP) and a second layer of pristine PLGA were fabricated. Two clinical bacterial isolates (

Indexed as

Ang1CAM assayCopper-doped tricalcium phosphateCopper oxideNanoparticlesqPCRVEGF

Identifiers

PMID38486752
PMCPMC10937708
OpenAlexW4392381907

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.